Analysis Oramed Pharmaceuticals Inc (ORMP)
5/30/2024
Analysis of Oramed Pharmaceuticals Inc (ORMP)
Oramed Pharmaceuticals Inc (ORMP) has been showing some volatility in its stock price over the past few days. The RSI indicator has been fluctuating around the mid-range, indicating a balanced market sentiment. The MACD indicator has been slightly negative, but the MACD histogram has shown some signs of improvement.The stock price has been moving within a range, with the 20-day Moving Average (MA) acting as a support level. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend.
Overall, Oramed Pharmaceuticals Inc seems to be consolidating after a period of volatility. Traders and investors may want to monitor the stock for a breakout above the recent range or a potential reversal from the current levels.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results before that, ending on January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at a specific time. However, the results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow TTM of $110.56 billion and levered free cash flow TTM of $84.73 billion. The balance sheet shows a total cash MRQ of $67.15 billion, total debt MRQ of $104.59 billion, and a current ratio MRQ of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue TTM of $381.62 billion, and a diluted EPS TTM of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The average 10-day volume is 46.86 million, while the average 90-day volume is 57.50 million. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics include a PEG ratio of 26.32, forward PE of 26.32, trailing PE of 29.59, and an enterprise value of $2.95 trillion. The price to book MRQ is 39.34, price to sales TTM is 7.65, enterprise to EBITDA is 22.76, and enterprise to revenue is 7.73. The market capitalization is $2.92 trillion.
The stock price summary shows a beta of 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The fifty-two-week low is $164.08, the high is $199.62, and the change is 6.85%.
Lastly, dividends and splits information includes a payout ratio of 14.93%, a dividend date of May 16, 2024, and an ex-dividend date of May 10, 2024. The last split date was August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating that the company may be facing higher production or acquisition costs.
3. The gross profit margin has remained relatively stable over the years, indicating that the company has been able to maintain its profitability despite the increase in costs.
4. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has been increasing over the years, reflecting the company's ability to manage its expenses and generate higher profits.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory, indicating that the company's profitability is improving on a per-share basis.
7. The company has been able to effectively manage its tax expenses, with the income tax amount increasing in line with the growth in revenue.
8. Overall, the financial performance of the company, as indicated by its revenues, shows a positive growth trend over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the past performance. However, the company is still projected to experience double-digit growth over the next 5 years according to analyst consensus.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has shown an overall increasing trend, with the highest value in 2023 at $73,812,000,000.
6. The company has been investing more in non-current assets over the years, indicating potential long-term growth strategies.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term, which should be carefully managed.
8. Retained earnings have been fluctuating, indicating varying profitability levels over the years.
9. The company has been maintaining a healthy cash position, which is essential for liquidity and operational stability.
10. Overall, the company's financial position seems stable, but attention should be paid to managing liabilities and optimizing asset utilization for sustained growth.
MACD of ORMP
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
